Jeff Capel­lo joins Bio­gen as CFO; Tesaro en­ters $500M loan agree­ment; Palatin li­cens­es fe­male li­bido drug to Ko­re­a's Kwang­don

→ Bio­gen has re­cruit­ed Jeff Capel­lo as CFO and ex­ec­u­tive vice pres­i­dent, fill­ing the po­si­tion a few months af­ter los­ing Paul Clan­cy to Alex­ion. Capel­lo, whose slate of pre­vi­ous em­ploy­ers spans Or­tho Clin­i­cal Di­ag­nos­tics, Boston Sci­en­tif­ic Cor­po­ra­tion and Perkin Elmer, jumps ship from Bea­con Health Op­tions, where he held the same roles. His fi­nan­cial ex­pe­ri­ence will like­ly be cru­cial for the big biotech $BI­IB as it ex­e­cutes a plan to “stream­line” op­er­a­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER